Dr. Otis Brawley speaks with Dr. Norma Kanarek from the Johns Hopkins Bloomberg School of Public Health about the Maryland Comprehensive Cancer Plan
Dr. John Groopman is the Anna M. Baetjer Professor of Environmental Health at the Johns Hopkins Bloomberg School of Public Health and the Associate Director for Cancer Prevention and Control at the Sidney Kimmel Comprehensive Cancer Center in the School of Medicine. Dr. Groopman’s research in molecular biomarkers is applied to practial cancer prevention strategies. (video)
The exposome is theoretically a comprehensive measurement of all exposure events (exogenous and endogenous) from conception to death. It encompasses life course environmental exposures including lifestyle factors from the prenatal period onwards.
Disparities can be separated in to two categories: Differences and inequities. While equity disparities such as discrimination, segregation and access can be modified, difference disparities such as genetics cannot.
Translational research is scientific research that facilitates the translation of findings from basic science to practical applications that enhance human health and well-being.
Cancer Prevention & Control News Feed
17th Annual Research Matters Conference | May 14, 2019
The Research Matters Conference highlights cancer research on the Maryland and Hopkins campuses related to and supported by the Cigarette Restitution Fund.
See the agenda below.
Liver Cancer on Rise, Aflatoxin Contributes, says Dr. John Groopman
Dr. Groopman gave the biannual NCI Stars in Nutrition and Cancer lecture in Lipsett Amphitheater.
“There are about 500 million HBV carriers worldwide,” said Groopman. “One hundred million people are expected to die in this century from [liver cancer].”
Clinical Trials: Hope and Anticipation (Video)
Clinical Trials: Words & Phases (Video)
Clinical Trials: Expectations, Realities and Challenges (Video)
Screening Diagnostics and Prevention Services
Should I Be Screened for Cancer?
Even if you don’t have any symptoms, you can still be checked for cancer. The tests used to see if you may have cancer or pre-cancer are called cancer screening tests. These screening tests are different for each kind of cancer, and there are new tests being developed each year.
Maryland Cancer Report
Maryland DHMH Cancer-Related Surveillance Data and Reports
Johns Hopkins geneticist Gregg Semenza wins Lasker Award for insights into how cells sense oxygen
Gregg L. Semenza, whose discoveries on how cells respond to low oxygen levels could result in treatments for illnesses ranging from cancer to diabetes, today was among three researchers given the 2016 Albert Lasker Basic Medical Research Award.
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer
Triple-negative breast cancer (TNBC) is a heterogeneous and clinically aggressive disease for which there is no targeted therapy. BET bromodomain inhibitors, which have shown efficacy in several models of cancer have not been evaluated in TNBC.
Maryland Stem Cell Research Fund: Funding Opportunities
The Maryland Stem Cell Research Fund provides a variety of grant programs for human stem cell research in the state of Maryland.
LOI Deadline is November 19, 2015 5:00pm. Application deadline is January 14, 2016
Call for Papers | Epidemiologic Reviews | 2017 Theme Issue (Volume 39)
The theme of the 2017 issue will be “Reducing cancer burden in the population: epidemiologic evidence to support policies, systems, and environmental changes”
Minority Training Program in Cancer Control Research Summer Institute applications open
The Minority Training Program in Cancer Control Research (MTPCCR) is now accepting applications for the annual “Careers in Cancer Disparities Research” Summer Institute set to take place on June 4-8, 2016 at UCSF and June 17-21, 2016 at UCLA. The deadline to apply is Friday, February 12, 2016 by 5pm (PST).
Calling healthcare providers: Free Online Training and CME Credits: Treating Tobacco Use in Maryland - Tools for Helping Your Patients Quit.
Two Friends, 40 Years, and One Fresh Cancer Prevention
Tom Kensler and John Groopman's Recipe for Keeping Cancer at Bay
Skirt size increase linked to breast cancer risk, study finds
Researchers found that an increase of one size every 10 years led to a 33 percent rise in the risk of postmenopausal breast cancer, while an increase of two sizes per decade led to a 77 percent rise in risk, according to the study in the journal BMJ Open.
Dr. Kala Viswanathan is quoted.
To Market, To Market! Northeast Market Re-Opens
Enzyme Revealed as Promising Target to Treat Asthma and Cancer
In experiments, Johns Hopkins Kimmel Cancer Center scientists have identified an enzyme involved in the regulation of immune system T cells that could be a useful target in treating asthma and boosting the effects of certain cancer therapies.
Under Armour makes $10M contribution to Johns Hopkins Kimmel Cancer Center
Gift will be used to construct, outfit new Under Armour LiveWell Center
Ban E-cigarettes in the Stadium
Dr. Norma Kanarek's letter to the editor of the Baltimore Sun regarding E-cigarettes at Opening Day
Kenneth J. Pienta, M.D., Selected as Director of Prostate Cancer Program
Kenneth J. Pienta, M.D., has been selected as the director of our Prostate Cancer Program. He is joined by two co-directors, Samuel R. Denmeade, M.D. and Shawn E. Lupold, Ph.D.
In his new role, Ken will facilitate the growth and development of our prostate and other GU cancer research activities. Ken is a Professor of Urology and Oncology and brings considerable previous leadership experience from the University of Michigan Medical School in Ann Arbor where he held positions as Director of Urologic Oncology and Associate Dean for Clinical and Translational Research.
Sam, whose clinical and basic science research has focused on the bringing promising new therapies to patients with prostate cancer, will continue his translational research efforts conducting innovative clinical trials through his clinical practice and developing new therapeutics in the lab.
Shawn is an Associate Professor of Urology, Oncology and Radiation Oncology and Molecular Radiation Sciences and his research focuses on prostate cancer biology with the goal of exploiting prostate and cancer tissue-specificity to develop new diagnostic, prognostic, and therapeutic agents.
2014 ASPO Conference American Society of Preventive Oncology 38th Annual Meeting March 8-11, 2014
American Society of Preventive Oncology
38th Annual Meeting
March 8-11, 2014
Hyatt Regency Crystal City
Vaccine Used to Treat Cervical Precancers Triggers Immune Cell Response
Preliminary results of a small clinical trial show that a vaccine used to treat women with high-grade precancerous cervical lesions triggers an immune cell response within the damaged tissue itself. The Johns Hopkins scientists who conducted the trial said the finding is significant because measuring immune system responses directly in the lesions may be a more accurate way to evaluate so-called "therapeutic" vaccines than by the conventional means of blood analysis.
An Update from the Sidney Kimmel Comprehensive Cancer Center on its Maryland Cigarette Restitution Funds
The Maryland Cancer Registry
Diane Dwyer and Cliff Mitchell describe the Maryland Cancer Registry and the data it collects. They also discuss the differences between the registry's data and information gathered by community members.
Psychology's Role in Smoking Decline Continues 50 Years After Surgeon General's Groundbreaking Report - Five questions for psychologist David B. Abrams, PhD
Fifty years ago, the U.S. Surgeon General’s Report on Smoking and Health prompted one of the largest public health behavior change success stories of the 20th century. Before and since this groundbreaking report’s release, psychology has been at the forefront of smoking cessation efforts.
Vote for the "Cancer Matters" Blog!
The Cancer Matters blog has been nominated for a Mobbie – a Baltimore Sun award for best blog among “Best Organization Blogs”. You can vote for the next couple days.
NCI Research to Reality Cyber-Seminar
Using New/Social Media for Cancer Control and Prevention
Workshops on NIH/NCI Grants for Graduate Students, Post Graduates and Early Investigators
The Johns Hopkins Center to Reduce Cancer Disparities of the Sidney Kimmel Comprehensive Cancer Center and the Professional Development Office Johns Hopkins Medical Institutions are hosting two different workshops on NIH/NCI grants for graduate/post graduate students and early investigators. Please use the following link to register.
For more information, please contact:
Ahmed Elmi, MPH, CHES
Community Relations Manager
Panel recommends revised cancer warning on consent form for indoor tanning
An advisory panel recommended Friday that the state Health Department revise language on its parental consent form for indoor tanning to specify that the practice can cause skin cancer.
Read more: http://www.baltimoresun.com/health/bs-hs-tanning-warning-20130927,0,1818920.story#ixzz2iUNxBVLB
CRF Cancer Grant Solicitation
The Cigarette Restitution Fund (CRF) research grant to Johns Hopkins will be funding faculty recruitment (within one year of appointment) and translational research project proposals in fiscal year 2014. Funded awards will begin on July 1st and end June 30th 2014.
Transforming Prostate Cancer
Detection, Diagnosis and Treatment - everything you need to know about prostate cancer.
The Coffey Way
This icon of cancer research shares his unlikely journey from the hills of Bristol Tennessee to Johns Hopkins Leadership
Johns Hopkins diabetes expert Fred Brancati dies at 53
He was director General Internal Medicine division at School of Medicine
Just Released! FY13 DoD ARP, BCRP, OCRP, PCRP, PRMRP Program
Recently released funding opportunities from these five Department of Defense (DoD) Research Programs:
Autism Research Program (ARP)
Breast Cancer Research Program (BCRP)
Ovarian Cancer Research Program (OCRP)
Prostate Cancer Research Program (PCRP)
Peer Reviewed Medical Research Program (PRMRP)
Johns Hopkins Oncologist Vogelstein Receives $3 million Life Sciences Award
Bert Vogelstein, a professor of oncology and pathology at Johns Hopkins and a pioneer in the field of cancer genomics, is among 11 scientists named the first winners of the world's richest academic prize for medicine and biology.
NSF recognizes JHU Professor for Cancer Treatment Research
Cui Receives CAREER Award for Work Involving Cancer-fighting Nanostructures
JHU Researchers Personalize Chemotherapy Drug Selection
Test uses cells from patients' tumors to help determine best treatment
HERA Women’s Cancer Foundation Ovarian Cancer Outside-the-Box (OSB) Seed Grant for 2013
The purpose of the OSB grant is to improve prevention and prognosis through innovative scientific research and to foster a strong long-term commitment to research in the field of ovarian cancer.
Hope for Early Test for Female Cancers
"This is really something that can be done as part of routine medical care," said Dr. Luis Diaz, lead researcher on the study.
New Tobacco Quitline Services for New Year, New Smoke-free Life Text support, 24/7 counseling among enhanced free services
The Maryland Department of Health and Mental Hygiene (DHMH), Center for Tobacco Prevention and Control (CTPC) today announced new services for the Maryland Tobacco Quitline
How Aggressive is the Cancer? Study of Telomeres May Lead to New Test
Alan Meeker and Elizabeth Platz: Telomeres, tiny regions at the ends of chromosomes,
get a bit shorter every time a cell divides. When they get too short, this can lead to cancer.
Guidelines limiting prostate cancer screening are widely ignored
Guidelines limiting PSA screening for prostate cancer detection in older men are widely ignored, researchers said Tuesday, and physicians seem likely to continue to ignore them. Craig E. Pollack is quoted.
An Update from the SKCCC on its Maryland Cigarette Restitution Funds- 2012
Continued Progress Hinges on the Return to Full CRF Funding
A Partnership in Cancer Prevention
Dr. John Groopman discusses the partnership between SKCCC, Howard University and the MD CRF.
John Groopman Discusses Phase 0 Cancer Prevention Trials
Cancer Prevention and Control expert John Groopman discusses natural methods to thwart cancer.
Biomarkers predict who may need prostate treatment
A blood test for certain forms of prostate specific antigen, or PSA, and measurement of DNA content in biopsy tissue accurately predict which men with potentially nonlethal prostate cancers may eventually need treatment, say Johns Hopkins scientists.
An Update on the Maryland Cigarette Resitiution Fund
Interview with John Groopman
Dr. Groopman talks about his landmark work in the field of hepatocellular carcinoma and the role of aflotoxins in the induction of this devastating liver cancer.
Heart drug may lead to prostate cancer treatment - Baltimore Sun
Elizabeth Platz, CRF investigator, quoted in Baltimore Sun
Surprise Finding: Pancreatic Cancers Progress to Lethal Stage Slowly
Pancreatic cancer develops and spreads much more slowly than scientists have thought, according to new research from Johns Hopkins investigators. The finding indicates that there is a potentially broad window for diagnosis and prevention of the disease.
Hear from CRF investigators
Young up and coming investigators and clinicians represent the future of cancer research and treatment.
YouTube Videos featuring CRF investigators
You Tube Videos (scan down for videos on CRF investigators Vasan Yegnasubrumanian and Sarah Wheelan.
Ten Big Stories of the Maryland CRF
CRF Research Grants Fill an Unmet Funding Need
Maryland Cigarette Restitution Fund Scientific Report is now available!
Please click on the attached PDF to view the report.
CPC Events Calendar
What's Happening This Week
CPC Program Activity
CRF FY '20 Recruitment and Retention
CRF Fy '20 Translational Application
Report Your Cancer Prevention and Control Activities
Want to stay informed of what's going on with our group? Then join our mailing list. Just add your email address below to start receiving our notifications.